pubmed· e01.org

PubMed · PMID 10946292

Proteolytic activities of two types of mannose-binding lectin-associated serine protease.

PMID 10946292Journal Journal of immunology (Baltimore, Md. : 1950)Year 2000Authors 5DOI 10.4049/jimmunol.165.5.2637

  • Source PubMed
  • Journal Journal of immunology (Baltimore, Md. : 1950)
  • Year 2000
  • Authors M Matsushita; S Thiel; J C Jensenius; I Terai; T Fujita
  • Licence NLM/PubMed terms

Abstract

Mannose (or mannan)-binding lectin (MBL) is an oligomeric serum lectin that plays a role in innate immunity by activating the complement system. In human, two types of MBL-associated serine protease (MASP-1 and MASP-2) and a truncated protein of MASP-2 (small MBL-associated protein; sMAP or MAp19) are complexed with MBL. To clarify the proteolytic activities of MASP-1 and MASP-2 against C4, C2, and C3, we isolated these two types of MASP in activated forms from human serum by sequential affinity chromatography.

On an anti-MASP-1 column, MASP-2 passed through the column in the presence of EDTA and high salt concentration, whereas MASP-1 was retained. Isolated MASP-1 and MASP-2 exhibited proteolytic activities against C3 and C4, respectively. C2 was activated by both MASPs. C1 inhibitor (C1 INH), an inhibitor for C1r and C1s, formed equimolar complexes with MASP-1 and MASP-2 and inhibited their proteolytic activities.

Record details

PMID10946292
PMCIDnot held
DOI10.4049/jimmunol.165.5.2637
JournalJournal of immunology (Baltimore, Md. : 1950)
Year2000
AuthorsM Matsushita; S Thiel; J C Jensenius; I Terai; T Fujita
Licencenot stated
MeSHBinding, Competitive; Carrier Proteins; Collectins; Complement Activation; Complement C1 Inactivator Proteins; Dose-Response Relationship, Immunologic; Enzyme Activation; Humans; Hydrolysis; Lectins; Mannose; Mannose-Binding Protein-Associated Serine Proteases; Serine Endopeptidases; Serine Proteinase Inhibitors

Source record

Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.

Source
PubMed / NLM
PMID
10946292
Rendered
2026-11-22
Completeness
abstract and citation fields